HIGHLIGHTS
- who: Shu Takeuchi et al. from the Department of Spinal Disorders Center, Fujieda Heisei Memorial Hospital, Shizuoka, Japan have published the research: Predictive Factors for Poor Outcome following Chemonucleolysis with Condoliase in Lumbar Disc Herniation, in the Journal: Medicina 2022, 1868 of /2022/
- what: The aim of this study was to determine the predictive factors for unsuccessful clinical outcome following condoliase therapy. This study showed that >80% of patients were classified into the G-group (without requirement for additional surgery), and that the mean NRS scores of leg pain and leg numbness significantly improved by . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.